To meet the most urgent needs of our customers in developing Nations, we leverage our International footprint and close relationships with the world’s leading pharmaceutical innovators to access and license USFDA / EMA registered biogenerics, transfer highly specialized knowledge, and maintain control over dependable supply chains.
We provide the expertise and capital necessary to develop state-of-the-art, efficient and highly scalable local manufacturing facilities, along with the experience and creativity needed to navigate regulatory approvals and commercialize new biogenerics in emerging markets.
Our approach is a significant departure from the conventional model, and yields superior results for individuals and for developing Nations.
